Goldman Sachs Says Buy Shire plc (SHPGY) On Recent Weakness, Keeps Top Rating
Tweet Send to a FriendGet Alerts SHPGY Hot Sheet
Price: $85.67 -0.2%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade SHPGY Now!
Goldman Sachs came out in defense of Shire plc (NASDAQ: SHPGY) Friday, saying the recent underperformance is unwarranted given strong fundamentals.
The firm notes Shire has underperformed peers by c.600 bp over the last week and c.1500 bp year-to-date.
"Shire's top-quartile industrial positioning drives its above sector revenue and EPS growth outlook, which we also believe is not reflected in its current valuation," the analyst said.
The firm notes the recent underperformance has been driven by skepticism associated with patent risk for Intuniv and maintenance of current status-quo for Adderall XR. They do not expect multi-source generics at least until 2014 at the earliest.
Goldman reiterated their Conviction Buy List rating.
For an analyst ratings summary and ratings history on Shire plc click here. For more ratings news on Shire plc click here.
Shares of Shire plc closed at $88.65 yesterday, with a 52 week range of $85.99-$108.79.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm notes Shire has underperformed peers by c.600 bp over the last week and c.1500 bp year-to-date.
"Shire's top-quartile industrial positioning drives its above sector revenue and EPS growth outlook, which we also believe is not reflected in its current valuation," the analyst said.
The firm notes the recent underperformance has been driven by skepticism associated with patent risk for Intuniv and maintenance of current status-quo for Adderall XR. They do not expect multi-source generics at least until 2014 at the earliest.
Goldman reiterated their Conviction Buy List rating.
For an analyst ratings summary and ratings history on Shire plc click here. For more ratings news on Shire plc click here.
Shares of Shire plc closed at $88.65 yesterday, with a 52 week range of $85.99-$108.79.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Compass Point Boosts Numbers on RLJ Lodging Trust (RLJ)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Goldman Sachs Conviction Buy List, Goldman Sachs
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
